Codon Devices is a privately-held biotechnology company focused on
enabling commercial applications of synthetic biology. The company's focus is on developing
and delivering high-value products and design services in a variety of
application areas, including engineered gene libraries, engineered
cells that produce novel pharmaceuticals, improved vaccines,
agricultural products, and biorefineries for the production of
industrial chemicals and...
more
Codon Devices is a privately-held biotechnology company focused on
enabling commercial applications of synthetic biology. The company's focus is on developing
and delivering high-value products and design services in a variety of
application areas, including engineered gene libraries, engineered
cells that produce novel pharmaceuticals, improved vaccines,
agricultural products, and biorefineries for the production of
industrial chemicals and Bio-energy. Founded in 2004,
Investors include Flagship Ventures, Alloy Ventures, Khosla Ventures,
Kleiner Perkins Caufield and Byers and Highland Capital.
